Micronisation processes, particularly micro- and nano-milling, are revolutionizing various industries like pharmaceuticals, food production, and battery material development by reducing particle sizes to enhance product properties. Frewitt’s latest innovations in micronisation equipment, specifically the FlexMills PMC-260 and PMC-260 Cryo, are set to showcase significant advancements in this field. These cutting-edge mills can achieve particle sizes ranging from 5 µm to 100 µm through micro-milling and 50 nm to 500 nm through nano-milling, thereby significantly increasing surface areas and improving properties like solubility and bioavailability, especially crucial in pharmaceutical applications.
The PMC-260 is a high-speed pin mill designed for production applications that demand high output of homogeneous, micronised granular products. With capabilities to achieve a fineness of 5 µm, the FlexMill integrates two milling processes into a single platform, offering a cost-effective solution for micronisation. Its design allows for processing batches ranging from 100g to 150 kg/h while maintaining a compact and modular structure that facilitates integration into various process flows. Moreover, the PMC-260 ensures consistent and reliable production in Good Manufacturing Practice (GMP) environments, making it suitable for pharmaceutical, battery, chemical, and food processing industries.
Innovation continues with the PMC-260 Cryo, which incorporates the same high-speed milling capabilities as the PMC-260 but with the added advantage of a Cryogenic Feeder CF-25. This integration enables the use of liquid nitrogen to freeze materials to their point of brittleness, facilitating powder size reduction. The mill’s versatility allows for demanding milling processes such as achieving optimum particle size distribution, milling temperature-sensitive products, and handling potentially explosive substances. With features like easy top-down cleaning, reduced product contact surface areas, and lower energy consumption, the PMC-260 Cryo ensures high-quality milled products, particularly useful for reducing polymer type products to powder while preserving product quality.
Frewitt’s nano-milling capabilities are crucial in the pharmaceutical industry for enhancing the bioavailability of Active Pharmaceutical Ingredients (APIs) by reducing their size to the nanometre range. This process, often requiring a sterile environment, is essential for improving dissolution rates and creating highly concentrated solutions. Similarly, in the battery market, homogenous particle size distributions of anode and cathode materials are vital for ensuring consistent conductivity and preserving active properties. The food industry also benefits from advanced milling technologies, such as in the production of probiotics, where particle size and density play a crucial role in maintaining shelf-life viability and incorporating probiotics into functional foods effectively.
Takeaways:
– Micronisation technologies like micro- and nano-milling are transforming industries by enhancing product properties through particle size reduction.
– Frewitt’s FlexMills PMC-260 and PMC-260 Cryo offer advanced solutions for micronisation processes in pharmaceutical, battery, chemical, and food sectors.
– Nano-milling plays a critical role in improving the bioavailability of APIs in pharmaceuticals and enhancing the properties of materials in battery and food industries.
– The ability to achieve precise particle sizes and densities through advanced milling processes is essential for maintaining product quality and viability in various sectors.
Tags: probiotics
Read more on pharmaceutical-technology.com